Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Applied Nanotech Board Elects Paul Rocheleau Vice-Chairman

Abstract:
Applied Nanotech Holdings, Inc. (OTC BB: APNT) announced that Paul Rocheleau has been elected Vice-Chairman of the Company's Board of Directors. In his role as Vice-Chairman, Paul will take an increased role in guiding company activities, with a focus on helping monetize our intellectual property by exposing it to strategic users with the ability to bring product rapidly to market and generate revenue for the Company.

Applied Nanotech Board Elects Paul Rocheleau Vice-Chairman

Austin, TX | Posted on November 23rd, 2009

Mr. Rocheleau has extensive experience in the global materials and chemicals industry. He is currently Chairman of the Board and Chief Investment Officer of Virginia Biosciences Commercialization Center. Over the past three years, he provided strategic and financial advisory services for a range of technology and industrial companies as a Managing Director at Cary Street Partners, a regional investment banking firm based in Richmond, Virginia. Prior experience included positions as Senior VP and Chief Financial Officer of Albermarle Corporation, a $2.0 Billion NYSE listed chemical company, and 15 years, including three as CEO, with Albright & Wilson, PLC, a $1.2 billion multinational chemical company.

Mr. Rocheleau currently serves on the Board of Directors of NanoChemonics, a specialty nano- materials company and serves on the Advisory Board Apex Systems, a $400 million IT staffing company. He also is a Founding Trustee of the Virginia Commonwealth University School of Engineering, where he currently serves as President of the Foundation.

"Paul has become integrally involved with us as a strategic advisor," said Doug Baker, Chief Executive Officer of APNT. "His new perspective has been invaluable to us and his increased level of involvement will be very helpful to us as we continue to increase our revenue and move the company to profitability."

"I am excited by the wealth of opportunities in front of us," said Paul Rocheleau, Director of APNT. "I am looking forward to helping bring these revolutionary technologies to market."

"All of our Board Members are working harder than ever to make the company successful," said Dr. Robert Ronstadt, Chairman of APNT. "It is encouraging to see that Paul is willing to go above and beyond the call of duty. His background in strategy and financing of emerging technologies will be very helpful in the years ahead."

The Company also announced that its updated website is live today. Investors are invited to submit comments or suggestions related to the website through the investor contact information on the website, or through the contact information [below].

Safe Harbor Statement
This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2008, and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at www.sec.gov or from our website listed above. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances.

####

About Applied Nanotech Holdings
Applied Nanotech Holdings, Inc. is a premier research and commercialization organization focused on solving problems at the molecular level. Its team of PhD level scientists and engineers work with companies and other organizations to solve technical impasses and create innovations that will create a competitive advantage. The business model is to license patents and technology to partners that will manufacture and distribute products using the technology. Applied Nanotech has over 250 patents or patents pending. APNT also possesses investments related to electronic digitized sign technology.

For more information, please click here

Contacts:
Doug Baker
Applied Nanotech Holdings, Inc.
248.391.0612

Copyright © Applied Nanotech Holdings

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

'Lasers rewired': Scientists find a new way to make nanowire lasers: Berkeley Lab, UC Berkeley scientists adapt next-gen solar cell materials for a different purpose February 12th, 2016

Breaking cell barriers with retractable protein nanoneedles: Adapting a bacterial structure, Wyss Institute researchers develop protein actuators that can mechanically puncture cells February 12th, 2016

Replacement of Toxic Antibacterial Agents Possible by Biocompatible Polymeric Nanocomposites February 12th, 2016

Properties of Polymeric Nanofibers Optimized to Treat Damaged Body Tissues February 12th, 2016

Announcements

Graphene leans on glass to advance electronics: Scientists' use of common glass to optimize graphene's electronic properties could improve technologies from flat screens to solar cells February 12th, 2016

Breaking cell barriers with retractable protein nanoneedles: Adapting a bacterial structure, Wyss Institute researchers develop protein actuators that can mechanically puncture cells February 12th, 2016

Replacement of Toxic Antibacterial Agents Possible by Biocompatible Polymeric Nanocomposites February 12th, 2016

Properties of Polymeric Nanofibers Optimized to Treat Damaged Body Tissues February 12th, 2016

Patents/IP/Tech Transfer/Licensing

New thin film transistor may lead to flexible devices: Researchers engineer an electronics first, opening door to flexible electronics February 10th, 2016

Joint Efforts by Iranian, Malaysian Scientists Produce Antibacterial Coatings for Isolated Areas February 4th, 2016

Silicon-based metamaterials could bring photonic circuits February 1st, 2016

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre: FDA Cleared Immuno-Oncology Technology to Resume Clinical Development for Solid Tumor Patients January 27th, 2016

Appointments/Promotions/New hires/Resignations/Deaths

NSS Pays Tribute to Late NSS Governor Dr. Marvin Minsky, A Pioneer in Artificial Intelligence February 11th, 2016

Tesla NanoCoatings Gains Talents of Joe Davis as Vice President-Sales Engineer January 27th, 2016

Semblant Appoints Donald Cunningham as Chief Commercial Officer January 2nd, 2016

Beneq introduces new growth strategy and company structure - Jukka Nieminen appointed President December 15th, 2015

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic